[An experience of the application of rispolept in childhood schizophrenia].

The efficiency of rispolept was examined in open non-comparative study which included 32 patients 6.5-16 years of age with schizophrenic spectrum disorders. Efficiency of the drug was estimated by clinical psychopathologic method together with the evaluation according to the PANSS.